Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iridex (IRIX)
:IRIX
Holding IRIX?
Track your performance easily
IRIX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.27 - $3.65
Previous CloseN/A
Volume8.51K
Average Volume (3M)40.47K
Market Cap
$27.12M
Enterprise Value$30.73M
Total Cash (Recent Filing)$23.75M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding16,636,380
10 Day Avg. Volume39,666
30 Day Avg. Volume40,474
Standard Deviation0.20
R-Squared0.05
Alpha0.00288
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.56
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.13
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit1.41
Enterprise Value/Ebitda-3.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Iridex News
PremiumCompany Announcements
Iridex CEO Patrick Mercer Joins Board of Directors
PremiumCompany Announcements
Iridex Leadership Changes and Strategic Appointments
PremiumCompany Announcements
Iridex Corporation’s Q3 2024 Financial Performance Overview
Ownership Overview
3.12% Insiders
4.51% Mutual Funds
11.44% Other Institutional Investors
77.42% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IRIX FAQ
What was Iridex’s price range in the past 12 months?
Iridex lowest stock price was $1.27 and its highest was $3.65 in the past 12 months.
What is Iridex’s market cap?
Iridex’s market cap is $27.12M.
When is Iridex’s upcoming earnings report date?
Iridex’s upcoming earnings report date is Mar 06, 2025 which is in 47 days.
How were Iridex’s earnings last quarter?
Iridex released its earnings results on Nov 12, 2024. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.09 by -$0.03.
Is Iridex overvalued?
According to Wall Street analysts Iridex’s price is currently Overvalued.
Does Iridex pay dividends?
Iridex does not currently pay dividends.
What is Iridex’s EPS estimate?
Iridex’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iridex have?
Iridex has 16,636,380 shares outstanding.
What happened to Iridex’s price movement after its last earnings report?
Iridex reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.09. Following the earnings report the stock price went up 34.043%.
Which hedge fund is a major shareholder of Iridex?
Currently, no hedge funds are holding shares in IRIX
---
Company Description
Iridex
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
---
IRIX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While there were challenges with a revenue decline and increased losses, positive steps have been taken towards cost reduction and strategic progress. The upcoming changes in glaucoma reimbursement and positive fourth-quarter outlook add optimism.Read More>---
Technical Analysis
Cutera
―
Lemaitre Vascular
―
Stereotaxis
―
ClearPoint Neuro
―
Irhythm Technologies
―
Precision Optics Corporation
―
---